CS logo
small CS logo
Oncology Center Sf. Nectarie

Craiova, Romania
Medical clinic in Craiova
Strada Caracal 23, Craiova

About Oncology Center Sf. Nectarie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
19
Eli Lilly and Company
4
Merck Sharp & Dohme LLC
4
Pfizer
4
Bristol-Myers Squibb
3
Amgen
2
Bayer
2
Boehringer Ingelheim
2
Daiichi Sankyo, Inc.
2
NanoCarrier Co., Ltd.
2
Asociatia Oncohelp - Centrul de Oncologie Oncohelp
1
Total Rows: 33

Clinical Trials at Oncology Center Sf. Nectarie


During the past decade, Oncology Center Sf. Nectarie conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 28 clinical trials were completed, i.e. on average, 49.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 15 clinical trials were completed. i.e. 115.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years121266779910105544440011116655228833Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib.
2009-12-16
2020-06-19
Completed
99
STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
2011-07-01
2017-06-14
Completed
1,232
A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
2012-06-06
2018-07-26
Completed
106
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
2013-06-10
2019-12-31
Completed
780
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
2013-04-01
2015-12-01
Terminated
696
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
2014-02-24
2020-06-27
Completed
707
A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer
2014-10-01
2017-09-20
Completed
714
Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients
2015-05-01
2019-09-06
Terminated
106

Rows per page:

1–67 of 67

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oncology Center Sf. Nectarie" #1 sponsor was "Hoffmann-La Roche" with 19 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 33 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Center Sf. Nectarie" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Gynecologic Oncology Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 19Hoffmann-La Roche: 19Eli Lilly and Company: 4Eli Lilly and Company: 4Merck Sharp & Dohme LLC: 4Merck Sharp & Dohme LLC: 4Pfizer: 4Pfizer: 4Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3Amgen: 2Amgen: 2Bayer: 2Bayer: 2Boehringer Ingelheim: 2Boehringer Ingelheim: 2Daiichi Sankyo, Inc.: 2Daiichi Sankyo, Inc.: 2NanoCarrier Co., Ltd.: 2NanoCarrier Co., Ltd.: 2

Created with Highcharts 11.1.0Top CollaboratorsAstraZeneca: 2AstraZeneca: 2Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Gynecologic Oncology Group: 2Gynecologic Oncology Group: 2Alliance FoundationTrials (AFT): 1Alliance FoundationTrials (AFT): 1Australasian LungCancer Trials Group: 1Australasian LungCancer Trials Group: 1BeiGene: 1BeiGene: 1BeiGene, Ltd.: 1BeiGene, Ltd.: 1Breast International Group: 1Breast International Group: 1Caris Life Sciences: 1Caris Life Sciences: 1Central and EasternEuropean OncologyGroup: 1Central and EasternEuropean OncologyGroup: 1

Clinical Trials Conditions at Oncology Center Sf. Nectarie


According to Clinical.Site data, the most researched conditions in "Oncology Center Sf. Nectarie" are "Breast Cancer" (5 trials), "Non-Small Cell Lung Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Gastric Cancer" (3 trials) and "Triple-Negative Breast Cancer" (3 trials). Many other conditions were trialed in "Oncology Center Sf. Nectarie" in a lesser frequency.

Clinical Trials Intervention Types at Oncology Center Sf. Nectarie


Most popular intervention types in "Oncology Center Sf. Nectarie" are "Drug" (59 trials), "Biological" (13 trials), "Other" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "Paclitaxel" (15 trials), "Carboplatin" (12 trials), "Cisplatin" (11 trials) and "Atezolizumab" (10 trials). Other intervention names were less common.

Clinical Trials Genders at Oncology Center Sf. Nectarie


The vast majority of trials in "Oncology Center Sf. Nectarie" are 57 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at Oncology Center Sf. Nectarie


Currently, there are NaN active trials in "Oncology Center Sf. Nectarie". undefined are not yet recruiting, 16 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Oncology Center Sf. Nectarie, undefined suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology Center Sf. Nectarie, 3 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 43Phase 3: 43Phase 2: 20Phase 2: 20Phase 1: 3Phase 1: 3Phase 4: 3Phase 4: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 24Completed: 24Active, not recruiting: 18Active, not recruiting: 18Recruiting: 16Recruiting: 16Terminated: 9Terminated: 9